Effectiveness of Different Approaches for the Rehabilitation of Gait in Patients With Parkinson's Disease
NCT ID: NCT03021408
Last Updated: 2017-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2017-01-31
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aquatic Therapy for Freezing of Gait in Parkinson's Disease Patients
NCT03015714
The Effects of Gait Rehabilitation After Stroke by Treadmill-based Robotics Versus Traditional Gait Training
NCT03688165
Innovative Models in the Rehabilitation of the Elderly With Parkinson's Disease Through Technological Innovation
NCT04087031
Robotic Gait Rehabilitation in Parkinson's Disease
NCT05218187
Virtual Reality and Robot Assisted Gait Training in Patients With Multiple Sclerosis
NCT02896179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It has been widely demonstrated that a multidisciplinary, intensive, goal-based, motor-cognitive and aerobic treatment (MIRT), specifically designed for PD patients, provide parkinsonians with motor and functional benefits. Nevertheless, the contribution provided by treadmill, treadmill-plus and VR on gait parameters has not been previously addressed within MIRT.
This study aims at investigating the superiority or the non-inferiority of these different devices in improving gait in PD patients in the context of MIRT.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MIRT + Treadmill
In the context of MIRT, the gait training in this group will be performed by using a treadmill without cues.
MIRT + Treadmill
PD patients will undergo a 4-week MIRT. All patients in the MIRT+Treadmill Plus group will undergo 10-minutes treadmill training twice per day, 5 times a week, for 4 weeks.
MIRT + Treadmill Plus
In the context of MIRT, the gait training in this group will be performed by using a treadmill with visual and auditory cues.
MIRT + Treadmill Plus
PD patients will undergo a 4-week MIRT. All patients in the MIRT+Treadmill Plus group will undergo 10-minutes treadmill-plus training (with visual and auditory cues) twice per day, 5 times a week, for 4 weeks.
MIRT + Virtual Reality
In the context of MIRT, the gait training in this group will be performed by using Virtual Reality with enhanced perceptions (visual, auditory, and haptic inputs).
MIRT + Virtual Reality
PD patients will undergo a 4-week MIRT. All patients in the MIRT+Virtual Reality (VR) group will undergo 10-minutes VR training with enhanced perceptions (visual, auditory, and haptic inputs), twice per day, 5 times a week, for 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MIRT + Treadmill
PD patients will undergo a 4-week MIRT. All patients in the MIRT+Treadmill Plus group will undergo 10-minutes treadmill training twice per day, 5 times a week, for 4 weeks.
MIRT + Treadmill Plus
PD patients will undergo a 4-week MIRT. All patients in the MIRT+Treadmill Plus group will undergo 10-minutes treadmill-plus training (with visual and auditory cues) twice per day, 5 times a week, for 4 weeks.
MIRT + Virtual Reality
PD patients will undergo a 4-week MIRT. All patients in the MIRT+Virtual Reality (VR) group will undergo 10-minutes VR training with enhanced perceptions (visual, auditory, and haptic inputs), twice per day, 5 times a week, for 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild to moderate stage of disease (stage 2-3) according to Hoehn \& Yahr scale;
* Ability to walk on treadmill;
* Visual and hearing capacity sufficient to perceive the cues;
* No cognitive impairment (Mini-Mental State Examination score ≥ 26);
* Stable pharmacological treatment since 2 weeks before admission and during rehabilitation;
Exclusion Criteria
* Occurrence of cardiovascular, orthopaedic, peripheral nerves, musculoskeletal and vestibular disorders which could affect patient's locomotion or balance;
* Neuropsychiatric disturbances;
* Severe dyskinesia;
* Severe freezing of gait;
50 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ospedale Generale Di Zona Moriggia-Pelascini
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frazzitta Giuseppe, MD
Role: STUDY_DIRECTOR
"Moriggia-Pelascini" Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
"Moriggia-Pelascini" Hospital
Gravedona Ed Uniti, Como, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ilaria Zivi, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OGZonaMP-PD Gait Rehab
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.